Enrico Atzori
Overview
Explore the profile of Enrico Atzori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
7
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castelli R, Atzori E, Delitala A, Masala S, Micheluzzi V, Ponti E, et al.
Front Cardiovasc Med
. 2025 Feb;
12:1508574.
PMID: 40013124
Introduction: Primary immune thrombocytopenia is an autoimmune bleeding disorder characterized by variable immune-mediated platelet destruction. These patients have reported thrombotic complications, both venous and arterial, in addition to bleeding. Splenectomy...
2.
Gallo F, DAddazio M, DAmico G, Della Rocca D, Mazzone P, Bordignon S, et al.
Cardiovasc Revasc Med
. 2025 Jan;
PMID: 39809689
Background: Antithrombotic therapy (AT) after left atrial appendage occlusion (LAAO) in patients with non-valvular atrial fibrillation (NVAF) has the purpose of preventing device related thrombosis (DRT), avoiding embolic events; nevertheless,...
3.
Merella P, Talanas G, Isgender M, Micheluzzi V, Atzori E, Bilotta F, et al.
ESC Heart Fail
. 2024 Aug;
11(6):4038-4045.
PMID: 39104131
Aims: A paucity of studies addressed sex-related differences in clinical outcomes in the long term following acute coronary syndrome (ACS) treated with percutaneous coronary intervention (PCI). In these patients, it...
4.
Merella P, Casu G, Chessa P, Atzori E, Bandino S, Deiana G
J Clin Med
. 2023 Dec;
12(24).
PMID: 38137773
Non-valvular atrial fibrillation (AF) and cerebral amyloid angiopathy (CAA) are two common diseases in elderly populations. Despite the effectiveness of oral anticoagulant therapy in cardioembolic stroke prevention, intracranial hemorrhage represents...
5.
Merella P, Talanas G, Lorenzoni G, Denurra C, Atzori E, Casu G
Eur Cardiol
. 2023 Oct;
18:e57.
PMID: 37860701
Non-valvular AF is a common clinical condition associated with an increased risk of thromboembolic complications. As a consequence, oral anticoagulant therapy (OAT) is the cornerstone of non-valvular AF management. Despite...
6.
Gallo F, Ronco F, DAmico G, Della Rocca D, Mazzone P, Bordignon S, et al.
Catheter Cardiovasc Interv
. 2023 Mar;
101(6):1144-1153.
PMID: 36924020
Aims: To compare outcomes of patients who underwent left atrial appendage occlusion (LAAO) for nonvalvular atrial fibrillation (NVAF) and contraindication to anticoagulants due to history of either gastrointestinal (GI) or...
7.
Casu G, Merella P, Lorenzoni G, Denurra C, Talana G, Atzori E
Eur Heart J Suppl
. 2022 Nov;
24(Suppl I):I57-I60.
PMID: 36380809
Atrial fibrillation (AF) is the most common arrhythmia. The most fearful complication of AF is represented by cardio-embolic stroke and 30% of ischaemic strokes are attributable to AF. The prevention...